ストックスクリーナーアプリを入手
0.00
100.00%
-17.16
アフターアワーズ：
1.46
1.46
+
前日終値:
$17.16
開ける：
$0
24時間の取引高:
0
Relative Volume:
0.00
時価総額：
$59.90M
収益：
$9.16M
当期純損益:
$-68.17M
株価収益率:
0.00
EPS:
-1.63
ネットキャッシュフロー:
$-80.16M
1週間 パフォーマンス:
-100.00%
1か月 パフォーマンス:
-100.00%
6か月 パフォーマンス:
-100.00%
1年 パフォーマンス:
-100.00%
1日の値動き範囲:
$0.00
$0.00
1週間の範囲:
$0.00
$0.00
52週間の値動き範囲:
$0.00
$23.28
Ikena Oncology Inc Stock (IKNA) Company Profile
IKNA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
IKNA
Ikena Oncology Inc
|
0.00 | 59.90M | 9.16M | -68.17M | -80.16M | -1.63 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.90 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
470.27 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
576.42 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
815.61 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
316.15 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Ikena Oncology Inc Stock (IKNA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-05-29 | ダウングレード | Wedbush | Outperform → Neutral |
| 2023-09-22 | 開始されました | Wedbush | Outperform |
| 2023-05-04 | 再開されました | H.C. Wainwright | Buy |
| 2021-12-23 | 開始されました | H.C. Wainwright | Buy |
| 2021-05-05 | 再開されました | Credit Suisse | Outperform |
| 2021-04-26 | 再開されました | Credit Suisse | Outperform |
| 2021-04-20 | 開始されました | Credit Suisse | Outperform |
| 2021-04-20 | 開始されました | Jefferies | Buy |
| 2021-04-20 | 開始されました | William Blair | Outperform |
すべてを表示
Ikena Oncology Inc (IKNA) 最新ニュース
Why Ikena Oncology Inc. stock could outperform in 2025Weekly Investment Summary & Fast Entry High Yield Stock Tips - newser.com
Applying big data sentiment scoring on Ikena Oncology Inc.July 2025 Trade Ideas & Smart Money Movement Alerts - newser.com
Using AI based signals to follow Ikena Oncology Inc.July 2025 Selloffs & Risk Managed Investment Strategies - newser.com
Why Ikena Oncology Inc. stock is favored by top institutions2025 Analyst Calls & Entry Point Strategy Guides - newser.com
What catalysts could drive Ikena Oncology Inc. stock higherMarket Performance Report & Verified Short-Term Trading Plans - newser.com
How Ikena Oncology Inc. stock trades during market volatilityJuly 2025 Reactions & Community Supported Trade Ideas - newser.com
Is Ikena Oncology Inc. stock attractive for growth ETFsQuarterly Market Summary & Precise Trade Entry Recommendations - newser.com
Ikena Oncology Inc. stock momentum explainedMarket Movement Recap & Accurate Entry and Exit Point Alerts - newser.com
What technical models suggest about Ikena Oncology Inc.’s comebackWeekly Profit Report & Free Low Drawdown Momentum Trade Ideas - newser.com
Will Ikena Oncology Inc. stock go up soon2025 Analyst Calls & Verified Entry Point Detection - newser.com
Can momentum traders help lift Ikena Oncology Inc.2025 Market Outlook & Expert Curated Trade Setups - newser.com
What analysts say about Ikena Oncology Inc stockFibonacci Retracement Levels & Small Entry Portfolio - earlytimes.in
Will Ikena Oncology Inc. stock recover after recent dropGap Down & Long-Term Investment Growth Plans - newser.com
What machine learning models say about Ikena Oncology Inc.Entry Point & Verified Short-Term Plans - newser.com
Is Ikena Oncology Inc. stock trading at a premium valuation2025 Technical Overview & Safe Capital Growth Stock Tips - newser.com
Does Ikena Oncology Inc. qualify in momentum factor screeningEarnings Performance Report & Daily Oversold Stock Bounce Ideas - newser.com
Using Bollinger Bands to evaluate Ikena Oncology Inc.2025 Market Outlook & Fast Entry and Exit Trade Plans - newser.com
Will Ikena Oncology Inc. continue its uptrendJuly 2025 Snapshot & Weekly Watchlist for Hot Stocks - newser.com
Ikena Oncology Inc. stock outlook for YEAR2025 Volatility Report & Stock Portfolio Risk Control - newser.com
United States Neurofibromatosis Type 2 Market Set to Surge with - openPR.com
Ikena Oncology Inc (IKNA) 財務データ
収益
当期純利益
現金流量
EPS
4.09%
0.09%
大文字化:
|
ボリューム (24 時間):